drugset

drugset / Trial / NCT01107782

Sildenafil and Uteroplacental Perfusion

NCT01107782 ↗

Phase 2/3 Unknown 70 enrolled Tehran University of Medical Sciences

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether sildenafil is effective and safe in the treatment of fetal growth restriction.

Timeline

Start: 2008-06
Primary completion: 2010-06
Completion: 2012-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	50 mg	Oral

Indications